Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform?

We recently compiled a list of the 7 Best Psychedelic Stocks to Buy According to Analysts. Silo Pharma, Inc. (NASDAQ:SILO) is one of the best psychedelic stocks on our list.

SILO reported on July 7 that its wholly owned subsidiary, QwikAgents, joined the NVIDIA Developer Program to support the advancement of its artificial intelligence agent integration platform. The program provides QwikAgents with access to NVIDIA’s AI software ecosystem, development tools, technical resources, and optimization support aimed at improving next-generation AI applications. QwikAgents’ platform is designed to automate complex business processes through autonomous AI agents capable of reasoning, executing tasks, and connecting with enterprise systems. The company expects these resources to help accelerate platform development as it expands solutions for organizations seeking scalable AI-driven operations.

Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform?

Separately, on June 29, Silo Pharma, Inc. (NASDAQ:SILO) announced that it had partnered with Resyca to conduct a robustness evaluation of the microchip-based nasal spray technology being developed for SPC-15, its lead intranasal treatment candidate for post-traumatic stress disorder. The study will assess device reliability during expected use and examine formulation stability over 30 days. SILO believes the nose-to-brain delivery approach may improve drug concentration in the brain while limiting systemic exposure, potentially supporting faster therapeutic effects and enhanced safety. The company is also using regulatory discussions with the FDA to advance development of SPC-15 through the streamlined 505 pathway.

Silo Pharma, Inc. (NASDAQ:SILO) is a developmental-stage biopharmaceutical company combining psychedelic research with traditional therapeutics to develop treatments for conditions such as PTSD, Alzheimer’s disease, multiple sclerosis, and chronic pain.

While we acknowledge the risk and potential of SILO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than SILO and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1